Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Publication of AR125411A1publicationCriticalpatent/AR125411A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La divulgación se refiere a métodos y a composiciones para el tratamiento de una enfermedad mediada por IFN de tipo I. En concreto, la divulgación se refiere a una dosis subcutánea de un inhibidor del receptor de IFN de tipo I.The disclosure relates to methods and compositions for the treatment of type I IFN-mediated disease. Specifically, the disclosure relates to a subcutaneous dose of a type I IFN receptor inhibitor.